THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Campbell & CO Investment Adviser LLC's Holding History (CIK: 0001353570)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 36,499 Value ($000) $683 Avg Close $16.59 Range $13.50 - $20.33
Q3 2025
Shares 52,617 Value ($000) $768 Avg Close $12.64 Range $10.82 - $14.87
Q2 2025
Shares 50,392 Value ($000) $556 Avg Close $9.72 Range $7.90 - $11.82
Q2 2024
Shares 44,180 Value ($000) $375 Avg Close $9.03 Range $8.13 - $10.44
Q1 2024
Shares 15,502 Value ($000) $139 Avg Close $9.27 Range $8.21 - $11.71
Q1 2022
Shares 25,100 Value ($000) $240 Avg Close $9.80 Range $7.71 - $13.17
Q3 2021
Shares 27,200 Value ($000) $201 Avg Close $11.19 Range $6.10 - $15.01
Q4 2019
Shares 8,928 Value ($000) $231 Avg Close $19.43 Range $15.72 - $26.47